BOSTON, March 24, 2025 /PRNewswire/ -- PhaseV, a leader in AI/ML-driven clinical development, announced today that it will ...

Clinical trials are becoming increasingly complex ... Join us for this valuable discussion for key insights into how AI is transforming workflows to help address today’s top data challenges.

Unveiling the power of AI in patient subgroups SOMS' AI-driven subgroup analysis is transforming clinical trials through real-time data processing and continuous tracking of patient subgroups.

We recently compiled a list of the Top 8 Trending AI Stock Updates On Wall Street Today. In this article, we are going to ...

a company advancing the next generation of clinical trials with AI, today announced that it has been awarded the prestigious Participant Engagement Award at the 2025 Summit for Clinical Ops Executives ...

AI-powered digital pathology specialist PathAI, based in Boston in the US, said that AIM-NASH AI Assist is designed to assist ...

The role of AI in supply chain management proved to be the focal issue at the recent 2025 Clinical Trial Supply Europe conference, as speakers discussed the risks to clinical trial supply in a ...

Summit Therapeutics' ivonescimab shows strong efficacy in trials, with Cantor Fitzgerald predicting a 50% market share in the ...

Summit Therapeutics (SMMT) announced a clinical trial collaboration with Pfizer (PFE) to evaluate ivonescimab, an investigational PD-1 / VEGF bispecific antibody, in combination with several of ...

MIAMI--(BUSINESS WIRE)--Summit Therapeutics Inc. (NASDAQ: SMMT) today announced a clinical trial collaboration with Pfizer Inc. (NYSE: PFE) to evaluate ivonescimab, a novel, investigational PD-1 ...